Clinical Trial Update: ImmunoMRI for Assessment of Tumor-associated Macrophages [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating ImmunoMRI as a biomarker to assess tumor-associated macrophages in diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Medical University of Vienna | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING